ArticleBMJ open2018

Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trial.

Claire Dahyot-Fizelier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.